Bruker Corporation Acquires Prolab Instruments GmbH
January 19, 2022
Bruker Corporation (Nasdaq: BRKR) has acquired Prolab Instruments GmbH, a Swiss developer of low-flow, high-precision UHPLC pumps, autosamplers and nano-/cap-LC systems, to strengthen its proteomics and metabolomics workflows. Financial terms were not disclosed; Bruker said the acquisition will accelerate product innovation and improve single-cell and high-sensitivity proteomics capabilities.
- Buyers
- Bruker Corporation
- Targets
- Prolab Instruments GmbH
- Industry
- Medical Devices
- Location
- Switzerland
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
Bruker Corporation Acquires Remaining Stake in TOFWERK AG
January 8, 2026
Manufacturing
Bruker Corporation acquired the remaining 60% ownership stake in TOFWERK AG, consolidating its ownership to 100%. The acquisition brings TOFWERK's compact, ultra-fast time-of-flight mass spectrometry technology and ~130 employees into Bruker's portfolio to expand capabilities and address applied markets such as air quality, semiconductor cleanroom monitoring, and food/flavors testing.
-
Bruker Corporation Acquires biocrates life sciences ag
June 3, 2025
Biotechnology
Bruker Corporation has acquired biocrates life sciences ag, an Innsbruck, Austria-based leader in mass-spectrometry-based quantitative metabolomics. The deal adds biocrates' metabolomics kits, assays, software and contract research services to Bruker's multiomics strategy, expanding Bruker's MS-based metabolomics and integrated multiomics capabilities. Financial terms were not disclosed.
-
Bruker Acquires Dynamic Biosensors GmbH
October 2, 2024
Biotechnology
Bruker Corporation has acquired Dynamic Biosensors GmbH, a Munich-based developer of single-cell interaction cytometry and biosensor instruments, to strengthen Bruker’s biosensors portfolio. The deal combines Dynamic Biosensors’ heliXcyto and heliX+ technologies with Bruker’s high-throughput SPR systems to expand capabilities and product offerings for drug discovery and biopharma research; financial terms were not disclosed.
-
Bruker Corporation Acquires NanoString Technologies Business
May 6, 2024
Medical Devices
Bruker Corporation has acquired substantially all assets of NanoString Technologies, Inc. through a court-supervised Chapter 11 asset sale for approximately $392.6 million in cash plus assumption of certain liabilities. The deal, announced April 2024 and closed in late April/early May 2024, brings NanoString's spatial biology and gene-expression product lines into Bruker to preserve customer access, product development, and jobs while expanding Bruker's life‑science instrumentation capabilities.
-
Bruker Corporation Acquires PepSep (nanoLC columns maker)
February 4, 2022
Medical Devices
Bruker Corporation acquired PepSep, a Danish maker of nanoflow liquid chromatography (nanoLC) columns, emitters and components to expand its timsTOF 4D‑Proteomics consumables portfolio. Financial terms were not disclosed; Bruker also announced an OEM agreement with IonOpticks to produce Bruker-branded high-performance pulled-tip columns.
-
Bruker Corporation Acquires Canopy Biosciences, LLC
September 11, 2020
Biotechnology
Bruker Corporation has acquired Canopy Biosciences, LLC to strengthen its targeted multi-omics and high-plex biomarker imaging capabilities, adding Canopy's ChipCytometry platform and multi-omics services. Financial terms were not disclosed; Ampersand Capital Partners was identified as Canopy's lead investor.
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.